$21.41
1.065.21%
Last update: Nov 9, 4:40 PM
Structure Therapeutics Inc
GPCRNASDAQ
The average analyst price target for Structure Therapeutics is $98.40, 359.8% above the current price. Of 15 analysts, 15 rate it Buy. Targets range from $65 to $140. The latest change came on Aug 7, 2026, when Citigroup lowered its price target on Structure Therapeutics from $100 to $97 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 15 Analysts
Rating Trend — Last 9 Months
